References
Allison, D. J., & Ditor, D. S. (2014). Immune dysfunction and chronic inflammation following spinal cord injury. Spinal Cord, 53(1), 14–18. https://doi.org/10.1038/sc.2014.184
Blais, L. L., Montgomery, T. L., Amiel, E., Deming, P. B., & Krementsov, D. N. (2021). Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review. Gut Microbes, 13(1). https://doi.org/10.1080/19490976.2021.1943289
Cardile, D., Calderone, A., De Luca, R., Corallo, F., Quartarone, A., & Calabrò, R. S. (2024). The Quality of Life in Patients with Spinal Cord Injury: Assessment and Rehabilitation. Journal of Clinical Medicine, 13(6), 1820. https://doi.org/10.3390/jcm13061820
Crowley, T., Cryan, J. F., Downer, E. J., & O’Leary, O. F. (2016). Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions. Brain Behavior and Immunity, 54, 260–277. https://doi.org/10.1016/j.bbi.2016.02.001
Darbandi, A., Asadi, A., Ari, M. M., Ohadi, E., Talebi, M., Zadeh, M. H., Emamie, A. D., Ghanavati, R., & Kakanj, M. (2021). Bacteriocins: Properties and potential use as antimicrobials. Journal of Clinical Laboratory Analysis, 36(1). https://doi.org/10.1002/jcla.24093
Daughton, C. G., & Ruhoy, I. S. (2012). Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment. The Science of the Total Environment, 443, 324–337. https://doi.org/10.1016/j.scitotenv.2012.10.092
Dopkins, N., Nagarkatti, P. S., & Nagarkatti, M. (2018). The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology, 154(2), 178–185. https://doi.org/10.1111/imm.12903
Faden, A. I., Wu, J., Stoica, B. A., & Loane, D. J. (2015). Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury. British Journal of Pharmacology, 173(4), 681–691. https://doi.org/10.1111/bph.13179
Fava, G. A., Cosci, F., Guidi, J., & Tomba, E. (2017). Well-being therapy in depression: New insights into the role of psychological well-being in the clinical process. Depression and Anxiety, 34(9), 801–808. https://doi.org/10.1002/da.22629
Freyermuth-Trujillo, X., Segura-Uribe, J. J., Salgado-Ceballos, H., Orozco-Barrios, C. E., & Coyoy-Salgado, A. (2022). Inflammation: a target for treatment in spinal cord injury. Cells, 11(17), 2692. https://doi.org/10.3390/cells11172692
Garcia-Arguello, L. Y., O’Horo, J. C., Farrell, A., Blakney, R., Sohail, M. R., Evans, C. T., & Safdar, N. (2016). Infections in the spinal cord-injured population: a systematic review. Spinal Cord, 55(6), 526–534. https://doi.org/10.1038/sc.2016.173
Ghassab, F. T., Mahmoudi, F. S., Tinjani, R. T., Meibodi, A. E., Zali, M. R., & Yadegar, A. (2024). Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights. Life Sciences, 350, 122748. https://doi.org/10.1016/j.lfs.2024.122748
Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A., & Covasa, M. (2022). Role of Microbiota-Gut-Brain axis in regulating dopaminergic signaling. Biomedicines, 10(2), 436. https://doi.org/10.3390/biomedicines10020436
Jamali, F., Mousavi, S., Homayouni-Rad, A., Meshkini, A., Alikhah, H., Houshyar, J., Moghadam, S. K., Yaghoubi, S. M., Asghari, K. M., Ilkhchi, M. T., & Alavi, S. a. N. (2025). Exploring Innovative Approaches for Managing Spinal cord Injury: A comprehensive review of promising probiotics and postbiotics. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-025-10513-6
Khalesi, S., Bellissimo, N., Vandelanotte, C., Williams, S., Stanley, D., & Irwin, C. (2018). A review of probiotic supplementation in healthy adults: helpful or hype? European Journal of Clinical Nutrition, 73(1), 24–37. https://doi.org/10.1038/s41430-018-0135-9
Lescheid, D. W. (2014). Probiotics as regulators of inflammation: A review. Functional Foods in Health and Disease, 4(7), 299. https://doi.org/10.31989/ffhd.v4i7.2
Leta, V., Chaudhuri, K. R., Milner, O., Chung-Faye, G., Metta, V., Pariante, C. M., & Borsini, A. (2021). Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence. Brain Behavior and Immunity, 98, 59–73. https://doi.org/10.1016/j.bbi.2021.07.026
Llewellyn, A., & Foey, A. (2017). Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events. Nutrients, 9(10), 1156. https://doi.org/10.3390/nu9101156
Mekhail, M., Almazan, G., & Tabrizian, M. (2012). Oligodendrocyte-protection and remyelination post-spinal cord injuries: A review. Progress in Neurobiology, 96(3), 322–339. https://doi.org/10.1016/j.pneurobio.2012.01.008
Preethy, S., Ranganathan, N., Raghavan, K., Dedeepiya, V. D., Ikewaki, N., & Abraham, S. J. (2022). Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders. Journal of Alzheimer S Disease, 87(4), 1451–1460. https://doi.org/10.3233/jad-220313
Ramsay, A. J., Kent, S. J., Strugnell, R. A., Suhrbier, A., Thomson, S. A., Ramshaw, I. A., Raima, A. J., Kent, S. J., Strugnell, R. A., Suhrbicr, A., Thomson, S. A., & Ramshaw, I. A. (1999). Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunological Reviews, 171(1), 27–44. https://doi.org/10.1111/j.1600-065x.1999.tb01341.x
Sarubbo, F., Cavallucci, V., & Pani, G. (2022). The influence of gut microbiota on neurogenesis: Evidence and hopes. Cells, 11(3), 382. https://doi.org/10.3390/cells11030382
Sedgwick, J. D., Schwender, S., Imrich, H., Dörries, R., Butcher, G. W., & Ter Meulen, V. (1991). Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proceedings of the National Academy of Sciences, 88(16), 7438–7442. https://doi.org/10.1073/pnas.88.16.7438
Shamsnia, H. S., Peyrovinasab, A., Amirlou, D., Sirouskabiri, S., Rostamian, F., Basiri, N., Shalmani, L. M., Hashemi, M., Hushmandi, K., & Abdolghaffari, A. H. (2024b). BDNF-TRKB signaling pathway in spinal cord injury: Insights and implications. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04381-4
Sichetti, M., De Marco, S., Pagiotti, R., Traina, G., & Pietrella, D. (2018). Anti-inflammatory effect of multistrain probiotic formulation ( L. rhamnosus, B. lactis, and B. longum ). Nutrition, 53, 95–102. https://doi.org/10.1016/j.nut.2018.02.005
Siddique, M. A. B., Debnath, A., Nath, N. D., Biswash, M. A. R., & Tufael. (2018, March 2). Advancing medical science through nanobiotechnology: Prospects, applications, and future directions. Journal of Primeasia, 1(1), 1–7. https://doi.org/10.25163/primeasia.1110163
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019). The pros, cons, and many unknowns of probiotics. Nature Medicine, 25(5), 716–729. https://doi.org/10.1038/s41591-019-0439-x
Suganya, K., & Koo, B. (2020). Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. International Journal of Molecular Sciences, 21(20), 7551. https://doi.org/10.3390/ijms21207551
Sun, Y., Wang, C., Wang, H., Yuan, Y., Lu, J., & Zhong, L. (2022). Probiotic in the prevention of ventilator-associated pneumonia in critically ill patients: evidence from meta-analysis and trial sequential analysis of randomized clinical trials. BMC Pulmonary Medicine, 22(1). https://doi.org/10.1186/s12890-022-01965-5
Tufael, M.?S.?B., Rana, M.?S., Das, S.?S., & Hossian, M. (2023). Nutritional evaluation of cassava meal components. Journal of Primeasia, 4(1), 1–4. https://doi.org/10.25163/angiotherapy.839572\
Umbrello, G., & Esposito, S. (2016). Microbiota and neurologic diseases: potential effects of probiotics. Journal of Translational Medicine, 14(1). https://doi.org/10.1186/s12967-016-1058-7
Venkatesh, K., Ghosh, S. K., Mullick, M., Manivasagam, G., & Sen, D. (2019). Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications. Cell and Tissue Research, 377(2), 125–151. https://doi.org/10.1007/s00441-019-03039-1
Wei, L., Ji, L., Miao, Y., Han, X., Li, Y., Wang, Z., Fu, J., Guo, L., Su, Y., & Zhang, Y. (2023). Constipation in DM are associated with both poor glycemic control and diabetic complications: Current status and future directions. Biomedicine & Pharmacotherapy, 165, 115202. https://doi.org/10.1016/j.biopha.2023.115202
Yadav, H., Jaldhi, N., Bhardwaj, R., Anamika, N., Bakshi, A., Gupta, S., & Maurya, S. K. (2023). Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review. Life Sciences, 330, 122022. https://doi.org/10.1016/j.lfs.2023.122022
Zhao, J., Yu, L., Zhai, Q., Tian, F., Zhang, H., & Chen, W. (2020). Effects of probiotic administration on hepatic antioxidative parameters depending on oxidative stress models: A meta-analysis of animal experiments. Journal of Functional Foods, 71, 103936. https://doi.org/10.1016/j.jff.2020.103936